MedPath

Investigation of the metabolism and toxicokinetics of the surfactant 2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD) in humans

Not Applicable
Conditions
Exposition of humans with TMDD
Registration Number
DRKS00022825
Lead Sponsor
Verband der Chemischen Industrie e.V.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
4
Inclusion Criteria

Healthy

Exclusion Criteria

Allergic persons
expectant mothers
breast-feeding mothers

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification of major metabolites of TMDD in human urine
Secondary Outcome Measures
NameTimeMethod
Toxicokinetics of the test compound and its major metabolites. By means of urine samples within 72 h after application
© Copyright 2025. All Rights Reserved by MedPath